The Basics
Compounding pharmacies can prepare certain substances for individual prescriptions. The FDA keeps lists of what is allowed. Peptides move on and off those lists.
The Timeline, Short Version
2020 to 2021: several peptides were flagged for review. 2023 to 2024: the FDA proposed restricting a group of peptides, including some recovery and growth-hormone peptides. 2025 to 2026: reviews continued; some substances were restricted, others reconsidered. The list is not final and we track it.
What It Means for You
Semaglutide and tirzepatide are FDA-approved drugs; compounding them is allowed under specific conditions. Most other peptides are not FDA-approved and are prescribed as compounded medications. If one you are taking becomes restricted, we stop prescribing it and work with you on an alternative. We never call a compounded peptide 'FDA-approved.'
Common Questions
Is BPC-157 banned?+
It has been under FDA review; status can change. We prescribe only what is currently permitted.
Are semaglutide and tirzepatide FDA-approved?+
The brand drugs are. Compounded versions are prepared under specific allowances.
Where can I check?+
Ask us. We keep the current list and tell you plainly.
All treatments are medical services. Every guest is screened, and every treatment is provided only under the clearance, prescription or standing protocol of a licensed medical provider. Compounded peptides are not FDA-approved unless stated. Nothing on this page is a diagnosis or a promise of results.